Clinical Trials Logo

Clinical Trial Summary

This randomized trial aims to compare the euploid rate of blastocysts in AMA patients undergoing PGT-A (preimplantation genetic testing for aneuploidy) with or without growth hormone supplement. Infertile patients ≥38 years old will be recruited for study after informed consent if they fulfill the inclusion criteria and do not have the exclusion criteria. Eligible women will be randomised into one of the two groups: Treatment group: Women will receive growth hormone (GH) supplement before and during antagonist protocol for ovarian stimulation. Control group: Women will receive antagonist protocol for ovarian stimulation. The primary outcome is the euploidy rate of blastocysts.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05447208
Study type Interventional
Source ShangHai Ji Ai Genetics & IVF Institute
Contact YILUN SUI, MD
Phone 86-13661553127
Email 08301010255@fudan.edu.cn
Status Recruiting
Phase Phase 3
Start date August 1, 2022
Completion date July 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT04079010 - The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone N/A
Completed NCT01540773 - Single Low-Dose of Supplement Amino Acid N/A
Completed NCT00562796 - Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal Obesity N/A
Completed NCT05574894 - Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort Study Phase 3
Completed NCT01158612 - The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella N/A
Completed NCT00966134 - Ghrelin, Growth Hormone and Growth Factors at High Altitude N/A
Active, not recruiting NCT06433375 - Evaluation of the Efficacy of Growth Hormone on Healing of Periapical Pathosis N/A